BridgeMD
New treatment option for Muscle Protein Synthesis
Official title Leucine Supplementation Strategies to Enhance Muscle Anabolic Responses in Older Age
ClinicalTrials.gov ID: NCT06567665
What this study is testing
- What it's testing
- Sarcopenia describes the progressive decline of muscle mass and strength with advancing age and is associated with increased frailty and morbidity, however we do not currently have an effective treatment. Protein feeding and exercise is known to increase muscle mass, but aged muscle shows a lower response to these stimuli leading to muscle loss over time.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 75, men only. Healthy volunteers may be eligible.
You may be able to join if
- Male, 65-75 years of age
- BMI 18-28 kg/m2
- Non smoker
- Not performing regular resistance type exercise
- Participant is willing and able to give informed consent for participation in the study
You likely can't join if
- A BMI \ 28 kg m-2
- Active cardiovascular disease: uncontrolled hypertension (BP \> 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac...
- Cerebrovascular disease: previous stroke, aneurysm (large vessel or intracranial)
- Respiratory disease including pulmonary hypertension or chronic obstructive pulmonary disease (COPD)
- Metabolic disease: hyper and hypo parathyroidism, untreated hyper and hypothyroidism, Cushing's disease, types 1 or 2 diabetes (treated and...
- Active inflammatory bowel disease
See the full eligibility criteria
- Male, 65-75 years of age
- BMI 18-28 kg/m2
- Non smoker
- Not performing regular resistance type exercise
- Participant is willing and able to give informed consent for participation in the study
- A BMI \ 28 kg m-2
- Active cardiovascular disease: uncontrolled hypertension (BP \> 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt or recent cardiac event
- Cerebrovascular disease: previous stroke, aneurysm (large vessel or intracranial)
- Respiratory disease including pulmonary hypertension or chronic obstructive pulmonary disease (COPD)
- Metabolic disease: hyper and hypo parathyroidism, untreated hyper and hypothyroidism, Cushing's disease, types 1 or 2 diabetes (treated and untreated), inborn/ congenital errors of metabolism (e.g. phenylketonuria...
- Active inflammatory bowel disease
- Acute infection
- Acute or chronic renal disease
- Malignancy (or history of malignancy with 5 y)
- Recent steroid treatment (within 6 mo), or hormone replacement therapy
- Coagulopathy
- Musculoskeletal or neurological disorders
- Known allergies to any of the product ingredients
- Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance
The study team makes the final eligibility decision.
Where it's taking place
- Nottingham, Nottinghamshire, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 65 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nottingham, Nottinghamshire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.